Cancer Prognosis
Research from Memorial Sloan Kettering Cancer Center, Department of Medicine in the area of cancer prognosis described
Published in Blood Weekly, October 30th, 2008
A new study, 'Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma,' is now available. "In a randomized, phase 3 trial, sunitinib demonstrated superior efficacy over interferon-alfa as first-line therapy in patients with metastatic clear-cell renal cell carcinoma (RCC). On the basis of outcome data from that trial, the authors developed a nomogram for predicting the probability of 12-month progression-free survival for patients who received sunitinib therapy," investigators in the United States report.
"Three-hundred seventy-five patients who received sunitinib in the phase 3 trial were the subject of the current analysis. Nomogram...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2008-10-30)
More Articles from Blood Weekly
- Cincinnati Children's Hospital Medical Center
Scientists trace molecular origin of proportional development - University of California - Riverside
Vitamin D a key player in overall health of several body organs, says UC Riverside biochemist - University of Melbourne
Smoking increases depression in women, Australian study reveals - Wiley-Blackwell
Kidney donation Web sites raise ethical concerns - World Journal of Gastroenterology
Why could ethyl pyruvate attenuate severe acute pancreatitis? - Acute Leukemia
Studies from University of Florence update current data on acute leukemia - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
